Orthofix Medical Cuts FY23 Revenue $752M-$758M To $739M-$744M Vs $754.63M Est.
Portfolio Pulse from Benzinga Newsdesk
Orthofix Medical has reduced its FY23 revenue forecast from $752M-$758M to $739M-$744M, which is below the estimated $754.63M.
November 08, 2023 | 9:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Orthofix Medical's lowered revenue forecast for FY23 may negatively impact its stock price in the short term.
Orthofix Medical's reduced revenue forecast for FY23 is a negative signal to investors, as it indicates potential challenges in the company's growth or profitability. This could lead to a decrease in demand for the company's stock, thereby negatively impacting its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100